Ignite Creation Date:
2024-05-06 @ 11:01 AM
Last Modification Date:
2024-10-26 @ 12:38 PM
Study NCT ID:
NCT03403777
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2018-01-02
Brief Title:
Avelumab in Refractory Testicular Germ Cell Cancer
Sponsor:
National Cancer Institute Slovakia
Organization:
National Cancer Institute Slovakia
Organization Data
Organization:
National Cancer Institute Slovakia
Class:
OTHER_GOV
Study ID:
NCISlovakia
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute Slovakia
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck KGaA Darmstadt Germany | INDUSTRY |